Last reviewed · How we verify
LMP specific T cells — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
LMP specific T cells (LMP specific T cells) — Baylor College of Medicine.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LMP specific T cells TARGET | LMP specific T cells | Baylor College of Medicine | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LMP specific T cells CI watch — RSS
- LMP specific T cells CI watch — Atom
- LMP specific T cells CI watch — JSON
- LMP specific T cells alone — RSS
Cite this brief
Drug Landscape (2026). LMP specific T cells — Competitive Intelligence Brief. https://druglandscape.com/ci/lmp-specific-t-cells. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab